Synopsis
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
Lead Product(s) : Esketamine Hydrochloride,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Supriya Lifescience Expands Global Footprint with Esketamine Hydrochloride Approval
Details : Esketamine is a Controlled Substance drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acute Pain.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
December 09, 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
11 Dec 2024
// PRESS RELEASE
24 Oct 2024
// PR NEWSWIRE
22 Jul 2024
// PRESS RELEASE
12 Jun 2024
// ACCESSWIRE
20 May 2024
// CONTRACT PHARMA
08 Oct 2023
// GLOBENEWSWIRE
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
17 Mar 2023
Reply
08 Jan 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF DOSSIERS
Reply
23 Feb 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
80
PharmaCompass offers a list of Esketamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Esketamine Hydrochloride manufacturer or Esketamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Esketamine Hydrochloride manufacturer or Esketamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Esketamine Hydrochloride API Price utilized in the formulation of products. Esketamine Hydrochloride API Price is not always fixed or binding as the Esketamine Hydrochloride Price is obtained through a variety of data sources. The Esketamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Esketamine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Esketamine Hydrochloride, including repackagers and relabelers. The FDA regulates Esketamine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Esketamine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Esketamine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Esketamine Hydrochloride supplier is an individual or a company that provides Esketamine Hydrochloride active pharmaceutical ingredient (API) or Esketamine Hydrochloride finished formulations upon request. The Esketamine Hydrochloride suppliers may include Esketamine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Esketamine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Esketamine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Esketamine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Esketamine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Esketamine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Esketamine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Esketamine Hydrochloride USDMF includes data on Esketamine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Esketamine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Esketamine Hydrochloride suppliers with USDMF on PharmaCompass.
A Esketamine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Esketamine Hydrochloride Certificate of Suitability (COS). The purpose of a Esketamine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Esketamine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Esketamine Hydrochloride to their clients by showing that a Esketamine Hydrochloride CEP has been issued for it. The manufacturer submits a Esketamine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Esketamine Hydrochloride CEP holder for the record. Additionally, the data presented in the Esketamine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Esketamine Hydrochloride DMF.
A Esketamine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Esketamine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Esketamine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Esketamine Hydrochloride written confirmation (Esketamine Hydrochloride WC) is an official document issued by a regulatory agency to a Esketamine Hydrochloride manufacturer, verifying that the manufacturing facility of a Esketamine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Esketamine Hydrochloride APIs or Esketamine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Esketamine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Esketamine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Esketamine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Esketamine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Esketamine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Esketamine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Esketamine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Esketamine Hydrochloride suppliers with NDC on PharmaCompass.
Esketamine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Esketamine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Esketamine Hydrochloride GMP manufacturer or Esketamine Hydrochloride GMP API supplier for your needs.
A Esketamine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Esketamine Hydrochloride's compliance with Esketamine Hydrochloride specifications and serves as a tool for batch-level quality control.
Esketamine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Esketamine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Esketamine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Esketamine Hydrochloride EP), Esketamine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Esketamine Hydrochloride USP).
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Share
Comment (8)
